ICT01 2588Alternative Names: ICT 012588; ICT 1&2; ICT01; Smart Bomb
Latest Information Update: 28 Jul 2016
At a glance
- Originator University of Bradford Institute of Cancer Therapeutics
- Developer Incanthera
- Class Antineoplastics; Colchicum alkaloids; Drug conjugates; Peptides
- Mechanism of Action Vascular disrupting agents
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Breast cancer; Colorectal cancer; Lung cancer; Prostate cancer